Pneumotox Online
v2.2
  • RSS Feed
  • Contact
  • News
  • Diagnosing DIRD
  • Browse
  • Available on AppStore Available on AppStore

The Drug-Induced Respiratory Disease Website

Philippe Camus, M.D.

Dijon, France

  • Home
  • Browse by »
  • Drugs
  • Patterns

Cabergoline

3

V.a Pleural effusion (uni- or bilateral) (can accompany DI-LDs)

2
Last update : 10/07/2012
 
Search
Advanced search
Identify causative drugs
Diagnosing DIRD
1
Drug and radiation history
2
Drug singularity - Correct identification of the drug
3
Consistent timing of exposure v. onset of symptoms
4
Clinical, imaging, BAL, pathological pattern consistent with the specific drug
5
Careful exlusion of another cause
6
Remission of symptoms with removal of drug
7
Recurrence with rechallenge (rarely advisable)
8
Causality assessment
More detailed checklist

Publications

[Pleural effusion and pulmonary hypertension in a patient with Parkinson disease treated with cabergoline].
Archivos de bronconeumologia 2009 Feb;45;100-2 2009 Feb
[Recurrent nerve paralysis and pleural effusion due to cabergoline].
Revista de neurologia 2008 Mar 16-31;46;382-3 2008 Mar 16-31
Pleural effusion and thickening due to cabergoline use in a patient with Parkinson's disease.
European journal of internal medicine 2005 Apr;16;129-131 2005 Apr

Powered by

  • ^
  • Contact
  • Cookies
  • About